An announcement from Atara Biotherapeutics ( (ATRA) ) is now available.
On March 31, 2025, Atara Biotherapeutics announced the departure of Eric Hyllengren, its Chief Financial Officer and Chief Operating Officer, effective March 31, 2025. Hyllengren will receive severance benefits and his 2024 annual cash bonus, and he will provide consulting services to the company until July 31, 2025. Concurrently, Yanina Grant-Huerta was appointed as the Chief Accounting Officer and principal accounting officer. Grant-Huerta, who has been with the company since 2020, previously served as Vice President of Financial Planning and Analysis.
More about Atara Biotherapeutics
YTD Price Performance: -53.88%
Average Trading Volume: 204,042
Technical Sentiment Signal: Buy
Current Market Cap: $38.26M
See more data about ATRA stock on TipRanks’ Stock Analysis page.